Status:
TERMINATED
Modular Prevention Bundle for Non-ventilator-associated Hospital-acquired Pneumonia (nvHAP)
Lead Sponsor:
University of Zurich
Conditions:
Hospital-acquired Pneumonia
Healthcare Associated Infection
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Background: Hospital acquired pneumonia (HAP) is divided in two distinct groups, ventilator-associated pneumonia (VAP) and non-ventilator-associated HAP (nvHAP). Although nvHAP occurs more frequently ...
Detailed Description
Methods Aim: With this mixed-methods study, we aim to investigate the impact of the implementation of a newly designed nvHAP prevention bundle on the nvHAP incidence rate among inpatients in our ter...
Eligibility Criteria
Inclusion
- The study population consists of all patients hospitalized in nine predefined medical and surgical departments and their corresponding wards chosen based on the following criteria
- nvHAP rate above the 50th percentile according to UHZ nvHAP data from the year 2017
- high absolute number of patients with nvHAP according to UHZ nvHAP data from the year 2017
- organizational structure, e.g. departments sharing same nursing or medical personnel
- representing both medical and surgical specialties.
Exclusion
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2020
Estimated Enrollment :
45000 Patients enrolled
Trial Details
Trial ID
NCT03361085
Start Date
January 1 2018
End Date
February 28 2020
Last Update
July 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Zurich, Dept. of Infectious Diseases and Hospital Epidemiology
Zurich, Canton of Zurich, Switzerland, 8091